Jump to content

Cancer Research UK: Difference between revisions

From Wikipedia, the free encyclopedia
Browse history interactively
← Previous editNext edit →
Content deleted Content added
VisualWikitext
RafikiSykes (talk | contribs)
15,695 edits
→Research: added information about the involvement of Cancer Research and the ICR in the discovery of abiraterone
Line 44: Line 44:
=== Research ===
=== Research ===
In the financial year 2010/11 the charity spent £332 million on cancer research projects (around 69% of its total income for that year). The bulk of the remaining costs were spent on trading and fundraising costs, with a small amount also spent on information services, campaigning and advocacy, administration, on other activities, or held in reserve.<ref name="Saving lives: Annual report 2010/11"/> The charity funds the work of over 4,000 researchers, doctors and nurses throughout the UK, supports over 200 clinical trials and studies cancer and cancer risk in over a million people in the UK.<ref>{{cite web|url=http://aboutus.cancerresearchuk.org/what-we-do/ |title=Cancer Research UK: What we do |publisher=Aboutus.cancerresearchuk.org |date=2011-03-31 |accessdate=2011-04-04}}</ref> Around 40% of the charity's research expenditure goes on basic laboratory research relevant to all types of cancer into the [[molecular]] basis of cancer. The research is intended to improve understanding of how cancer develops and spreads and thus provide a foundation for other research.<ref>{{cite web|url=http://aboutus.cancerresearchuk.org/what-we-do/our-annual-publications-and-strategy/5-year-strategy/ |title=Cancer Research UK: Our strategy 2009-2014 |publisher=Aboutus.cancerresearchuk.org |date= |accessdate=2011-04-04}}</ref> The rest of its funding is used to support research into over 100 specific cancer types, focusing on key areas such as [[drug discovery]] and development; prevention, early detection and [[Medical imaging|imaging]]; surgery and [[radiotherapy]]; and cancers where survival is still low, such as oesophageal, lung and pancreatic cancers.<ref>http://aboutus.cancerresearchuk.org/what-we-do/our-annual-publications-and-strategy/annual-report-and-accounts/</ref>
In the financial year 2010/11 the charity spent £332 million on cancer research projects (around 69% of its total income for that year). The bulk of the remaining costs were spent on trading and fundraising costs, with a small amount also spent on information services, campaigning and advocacy, administration, on other activities, or held in reserve.<ref name="Saving lives: Annual report 2010/11"/> The charity funds the work of over 4,000 researchers, doctors and nurses throughout the UK, supports over 200 clinical trials and studies cancer and cancer risk in over a million people in the UK.<ref>{{cite web|url=http://aboutus.cancerresearchuk.org/what-we-do/ |title=Cancer Research UK: What we do |publisher=Aboutus.cancerresearchuk.org |date=2011-03-31 |accessdate=2011-04-04}}</ref> Around 40% of the charity's research expenditure goes on basic laboratory research relevant to all types of cancer into the [[molecular]] basis of cancer. The research is intended to improve understanding of how cancer develops and spreads and thus provide a foundation for other research.<ref>{{cite web|url=http://aboutus.cancerresearchuk.org/what-we-do/our-annual-publications-and-strategy/5-year-strategy/ |title=Cancer Research UK: Our strategy 2009-2014 |publisher=Aboutus.cancerresearchuk.org |date= |accessdate=2011-04-04}}</ref> The rest of its funding is used to support research into over 100 specific cancer types, focusing on key areas such as [[drug discovery]] and development; prevention, early detection and [[Medical imaging|imaging]]; surgery and [[radiotherapy]]; and cancers where survival is still low, such as oesophageal, lung and pancreatic cancers.<ref>http://aboutus.cancerresearchuk.org/what-we-do/our-annual-publications-and-strategy/annual-report-and-accounts/</ref>

On the 21st September 2011, [[Sky News]] reported on the [[UK]] release of [[abiraterone]], a new [[drug]] used to treat advanced [[prostate cancer]]. The drug was discovered by Cancer Research UK and the Institute Of Cancer Research, before extensive testing on [[British]] men. Dr Heather Payne, a consultant at [[The Prostate Centre]] in [[London]], told [[Sky News]]: ''"This is a big breakthrough. It became quite obvious during the trial which men were being treated with the drug rather than the placebo dummy pill."''


=== Information services ===
=== Information services ===

Revision as of 11:02, 21 September 2011

Cancer Research UK
FoundedFebruary 4, 2002 (2002-02-04)
TypeCharitable organisation
Registration no.England and Wales: 1089464 Scotland: SC041666
FocusCancer research, Health policy
Location
  • Angel Building, 407 St John Street, London, EC1V 4AD
Coordinates51°31′54″N 0°06′24″W / 51.531545°N 0.106587°W / 51.531545; -0.106587
Area served
United Kingdom
Key people
Harpal Kumar
Revenue
£483 million (2011)[1]
Employees
3,985 (2011)[1]
Volunteers
40,000 (2011)[1]
Websitewww.cancerresearchuk.org
Formerly called
Imperial Cancer Research Fund, The Cancer Research Campaign

Cancer Research UK is a cancer research and awareness charity in the United Kingdom,[2] formed on 4 February 2002 by the merger of The Cancer Research Campaign and the Imperial Cancer Research Fund.[3] Its aim is to reduce the number of deaths from cancer. As the world's largest independent cancer research charity[4][5] it conducts research into the prevention, diagnosis and treatment of the disease. Research activities are carried out in institutes, universities and hospitals across the UK, both by the charity's own employees and by its grant-funded researchers. It also provides information about cancer and runs campaigns aimed at raising awareness of the disease and influencing public policy.[6][7] [8]

Cancer Research UK's work is entirely funded by the public. It raises money through donations, legacies, community fundraising, events, retail and corporate partnerships. Over 40,000 people are regular volunteers.[1]

History

The Imperial Cancer Research Fund (ICRF) was founded in 1902 as the Cancer Research Fund, changing its name to the Imperial Cancer Research Fund two years later. The charity grew over the next twenty years to become one of the world's leading cancer research charities.[9] Its flagship laboratories at Lincoln's Inn Fields and Clare Hall are now known as the Cancer Research UK London Research Institute.[4]

The British Empire Cancer Campaign (BECC) was founded in 1923, and initially drew a hostile response from ICRF and the Medical Research Council, who considered it a rival.[9][10] "The Campaign", as it was colloquially known, became a very successful and powerful grant-giving body. In 1970, the charity was renamed The Cancer Research Campaign (CRC).[10]

In 2002 the two charities agreed to merge to form Cancer Research UK, the largest independent research organisation in the world dedicated to fighting cancer (The largest, the National Cancer Institute, is funded by the US Government).[11][12] At the time of the merge, the ICRF had an annual income of £124m, while the CRC has an income of £101m.[11]

Activities

Research

In the financial year 2010/11 the charity spent £332 million on cancer research projects (around 69% of its total income for that year). The bulk of the remaining costs were spent on trading and fundraising costs, with a small amount also spent on information services, campaigning and advocacy, administration, on other activities, or held in reserve.[1] The charity funds the work of over 4,000 researchers, doctors and nurses throughout the UK, supports over 200 clinical trials and studies cancer and cancer risk in over a million people in the UK.[13] Around 40% of the charity's research expenditure goes on basic laboratory research relevant to all types of cancer into the molecular basis of cancer. The research is intended to improve understanding of how cancer develops and spreads and thus provide a foundation for other research.[14] The rest of its funding is used to support research into over 100 specific cancer types, focusing on key areas such as drug discovery and development; prevention, early detection and imaging; surgery and radiotherapy; and cancers where survival is still low, such as oesophageal, lung and pancreatic cancers.[15]

On the 21st September 2011, Sky News reported on the UK release of abiraterone, a new drug used to treat advanced prostate cancer. The drug was discovered by Cancer Research UK and the Institute Of Cancer Research, before extensive testing on British men. Dr Heather Payne, a consultant at The Prostate Centre in London, told Sky News: "This is a big breakthrough. It became quite obvious during the trial which men were being treated with the drug rather than the placebo dummy pill."

Information services

The charity provides information to the general public, the scientific community and healthcare professionals. Through CancerHelp UK, a website written in Plain English for anyone affected by cancer, it provides information on cancer and cancer care, and a unique clinical trials database.[3] A specialist team of cancer information nurses provides a confidential telephone service, the Cancer Chat forum provides a place for users to talk to others affected by cancer, and mobile cancer awareness units deliver health information to locations where cancer incidence and mortality are higher than average.

Cancer Research UK also publishes a twice-monthly professional medical journal, the British Journal of Cancer.

Influencing public policy

The charity works with the UK governments to inform and improve cancer services. It worked to bring about the smokefree workplaces legislation and continues to campaign for further action on smoking.[16] The charity lobbies for better screening programmes and advises on access to new cancer medicines, amongst other issues.

Partnerships

The charity works in partnership with other organisations. These include the UK Department of Health, the Wellcome Trust, the National Health Service, NICE, and the National Cancer Intelligence Network. It is one of the partners in the National Cancer Research Institute which also includes the Medical Research Council (UK) and the Leukemia Research Fund.[17] It is also a partner in the planned Francis Crick Institute.[18]

Animal testing

In June 2011 it was reported that the animal rights organisation Animal Aid plans to place a series of adverts in British newspapers urging members of the public to stop giving donations to Cancer Research UK and the British Heart Foundation, the Alzheimer's Society and Parkinson's UK unless they cease their support for research which involves animal testing.[19][20]

See also

References

  1. ^ a b c d e [1], Cancer Research UK, published 27 July 2011
  2. ^ "Cancer Research UK, registered charity no. 1089464". Charity Commission for England and Wales.
  3. ^ a b Gaze, Mark N.; Wilson, Isobel M. (15 July 2002). Handbook of Community Cancer Care. Cambridge University Press. p. 272. ISBN 9781841100012. Retrieved 31 January 2011.
  4. ^ a b ""Cancer charity mega-merger"". BBC News. 11 December 2001.
  5. ^ http://www.charitiesdirect.com/charities/top500.php
  6. ^ "Annual Report and Accounts" (PDF). 2001-12-11. Retrieved 2011-04-04.
  7. ^ http://aboutus.cancerresearchuk.org/prod_consump/groups/cr_common/@abt/@gen/documents/generalcontent/cr_043577.pdf Report on 2008/9 research activities
  8. ^ http://aboutus.cancerresearchuk.org/prod_consump/groups/cr_common/@abt/@gen/documents/generalcontent/cr_075376.pdf Annual Review 2010/11
  9. ^ a b Austoker, Joan. A history of the Imperial Cancer Research Fund, 1902-1986. Oxford University Press, 1988.
  10. ^ a b Cancer Research Campaign formerly British Empire Cancer Campaign, 1923-1981. Wellcome Library Archive. Retrieved 1 February 2011
  11. ^ a b World's biggest cancer charity formed, The Guardian, 4 February 2002.
  12. ^ "Cancer Research UK". Nat. Cell Biol. 4 (3): E45. 2002. doi:10.1038/ncb0302-e45. PMID 11875441. {{cite journal}}: Unknown parameter |month= ignored (help)
  13. ^ "Cancer Research UK: What we do". Aboutus.cancerresearchuk.org. 2011-03-31. Retrieved 2011-04-04.
  14. ^ "Cancer Research UK: Our strategy 2009-2014". Aboutus.cancerresearchuk.org. Retrieved 2011-04-04.
  15. ^ http://aboutus.cancerresearchuk.org/what-we-do/our-annual-publications-and-strategy/annual-report-and-accounts/
  16. ^ "Chief medic considered quitting". BBC News. 24 November 2005. Retrieved 1 February 2011.
  17. ^ Rafi, Imran (4 January 2006). An Introduction to the Use of Anticancer Drugs. Elsevier Health Sciences. p. 12. ISBN 9780750688307. Retrieved 31 January 2011.
  18. ^ "Project Press Release". UK Centre for Medical Research and Innovation web site. 21 June 2010. Retrieved 11 August 2010.
  19. ^ "Animal rights group declares war on leading health charities". The Independent. 21 June 2011. Retrieved 9 July 2011.
  20. ^ http://news.scotsman.com/science/Charities-are--attacked-over.6788444.jp


Retrieved from "https://en.wikipedia.org/w/index.php?title=Cancer_Research_UK&oldid=451656471"